Align Technology, Inc. (ALGN) Stock Price Today
Aura AI Summary
Key Stats
- $11.86BMarket Cap
- 665,710Volume
- HealthSector
- $197.5152W High
- $132.2852W Low
- 46 DaysTypical Hold Time
- $10.87BEnterprise Value
- -Div Yield
- -Trading Activity
Track Align Technology, Inc. (ALGN) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Align Technology, Inc. has traded between a low of $132.28 and a high of $197.51, highlighting its annual price range. Buy and sell Align Technology, Inc. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Align Technology, Inc.
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Most Recent News
Dassault Systèmes targets double-digit revenue and EPS growth by 2029 with AI-driven industrial solutions.
Dassault Systèmes announced at its 2026 Capital Markets Day a new growth cycle aiming for double-digit revenue and EPS growth by 2029, targeting over €8 billion in revenue and €1.80 in non-IFRS diluted EPS. The company highlights its transition to su...

SBM Offshore wins contract to build and operate Longtail FPSO in Guyana for 10 years
SBM Offshore has secured contracts from ExxonMobil Guyana to construct and operate a Floating Production, Storage and Offloading vessel (FPSO) for the Longtail development in Guyana's Stabroek Block. The FPSO will process 1.2 billion cubic feet of ga...

Agilon Health rated HOLD with 14.6% downside risk amid uncertain earnings and contract risks.
Agilon Health is rated HOLD with a 12-month price target of $98, which is 14.6% below its recent closing price of $114.81. The company’s margin upgrade for 2026 was driven by rising patient risk scores, especially in Ohio and Texas ACOs, but the sust...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.